Severe steroid refractory gastritis induced by Nivolumab: A case report

doi:10.3748/wjg.v26.i16.1971

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 16

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8065)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

489

WORD

168

HTML

4631

Figures (1-4)

312

Tables (1-1)

296

Sum=5896

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

849

Download

1320

Sum=2169

Apr 28, 2020 (publication date) through Nov 29, 2024

Times Cited of This Article

Times Cited (19)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Apr 28, 2020; 26(16): 1971-1978
Published online Apr 28, 2020. doi: 10.3748/wjg.v26.i16.1971

Full Size Figure Download Figure

Figure 4 The second positron emission tomography with computed tomography performed 10 wk after the first Infliximab administration. This showed a normal gastric wall with no fluorodeoxyglucose uptake.

Citation: Vindum HH, Agnholt JS, Nielsen AWM, Nielsen MB, Schmidt H. Severe steroid refractory gastritis induced by Nivolumab: A case report. World J Gastroenterol 2020; 26(16): 1971-1978
URL: https://www.wjgnet.com/1007-9327/full/v26/i16/1971.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i16.1971